famotidine has been researched along with carbamates in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bendell, JC; Clary, DO; Dickson, MA; Edelman, G; Gordon, MS; Johnston, SH; Kudchadkar, RR; LoRusso, PM; Schwartz, GK | 1 |
1 trial(s) available for famotidine and carbamates
Article | Year |
---|---|
Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Benzimidazoles; Carbamates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Antagonism; Famotidine; Female; Food-Drug Interactions; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; raf Kinases | 2015 |